{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:05:08Z","timestamp":1793747108095,"version":"4.6.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2023\/49\/B\/NZ7\/02469"],"award-info":[{"award-number":["2023\/49\/B\/NZ7\/02469"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108863","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T21:50:42Z","timestamp":1754862642000},"page":"108863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["New dimension of ciprofloxacin hybrids: Synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives"],"prefix":"10.1016","volume":"164","author":[{"given":"Dominik","family":"Koszelewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Ostaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleta","family":"Zaremba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Riganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kopecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialessandra","family":"Contino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilza","family":"Pajeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanka","family":"Tsakovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Saponara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denitsa","family":"Stefanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Tzankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yordan","family":"Yordanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108863_bb0005","series-title":"Estimated number of new cases from 2020 to 2040, Incidence, Both sexes, age [0\u201385+]","author":"WHO International Agency for Research on Cancer","year":"2020"},{"key":"10.1016\/j.bioorg.2025.108863_bb0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108863_bb0015","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.108863_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108863_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP\u2013dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108863_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming Cancer multi-drug resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108863_bb0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bioorg.2025.108863_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111970","article-title":"Ciprofloxacin and levofloxacin as potential drugs in genitourinary cancer treatment\u2014the effect of dose\u2013response on 2D and 3D cell cultures","volume":"22","author":"Kloskowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108863_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","article-title":"Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells","volume":"86","author":"Herold","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108863_bb0050","first-page":"1727","article-title":"Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53\/Bax\/Bcl-2 signaling pathway","volume":"52","author":"Beberok","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2025.108863_bb0055","doi-asserted-by":"crossref","unstructured":"Peter, S., Aderibigbe, B.A. Ciprofloxacin and Norfloxacin hybrid compounds: potential anticancer agents. Curr. Top. Med. Chem. 24 (n.d.) 644-665.","DOI":"10.2174\/0115680266288319240206052223"},{"key":"10.1016\/j.bioorg.2025.108863_bb0060","first-page":"11","article-title":"Antimicrobial peptides in human skin disease","volume":"18","author":"Kenshi","year":"2008","journal-title":"Eur. J. Dermatol. EJD"},{"key":"10.1016\/j.bioorg.2025.108863_bb0065","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.bbamem.2017.09.008","article-title":"Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes","volume":"1859","author":"Starr","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2025.108863_bb0070","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.3390\/ijms25094919","article-title":"Advancements in synthetic strategies and biological effects of ciprofloxacin derivatives: A review","volume":"25","author":"Khwaza","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108863_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29225382","article-title":"Unveiling the anticancer potential of a new ciprofloxacin-chalcone hybrid as an inhibitor of topoisomerases I & II and apoptotic inducer","volume":"29","author":"Ali","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108863_bb0080","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2174\/1568026620666200603105644","article-title":"Antiproliferative activity of 8-methoxy ciprofloxacin-Hydrozone\/Acylhydrazone scaffolds","volume":"20","author":"Wang","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111810","article-title":"Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates","volume":"185","author":"Chrzanowska","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0090","doi-asserted-by":"crossref","first-page":"18663","DOI":"10.1021\/acsomega.3c00554","article-title":"N-Acylated ciprofloxacin derivatives: synthesis and in vitro biological evaluation as antibacterial and anticancer agents","volume":"8","author":"Struga","year":"2023","journal-title":"CS Omega"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108863_bb0095","first-page":"207","article-title":"Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells","volume":"21","author":"El-Rayes","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2025.108863_bb0100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2004.02.004","article-title":"The combination of tamoxifen and 9cis retinoic acid exerts overadditive anti-tumoral efficacy in rat hepatocellular carcinoma","volume":"40","author":"Ganslmayer","year":"2004","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108863_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-010-1315-z","article-title":"Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy","volume":"67","author":"Pinto","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108863_bb0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00280-008-0892-6","article-title":"Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule dependent manner","volume":"64","author":"Pinto","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108863_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104383","article-title":"Synthesis and biological assessment of ciprofloxacin-derived 1,3,4-thiadiazoles as anticancer agents","volume":"105","author":"Ahadi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122093","article-title":"A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer","volume":"296","author":"Alhaj-Suliman","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2025.108863_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/aps.2011.158","article-title":"Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells","volume":"33","author":"Shi","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2025.108863_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1134\/S107042802204011X","article-title":"Synthesis, anticancer evaluation, and in silico modeling study of some N-Acylated ciprofloxacin derivatives","volume":"58","author":"Akhtar","year":"2022","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0135","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.3390\/ijms21134696","article-title":"Conjugates of ciprofloxacin and levofloxacin with cell-penetrating peptide exhibit antifungal activity and mammalian cytotoxicity","volume":"21","author":"Ptaszy\u0144ska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108863_bb0140","first-page":"134","article-title":"Recent strategies in design of antitumor and antibacterial fluoroquinolones","volume":"4","author":"Samir","year":"2021","journal-title":"J. Adv. Biomed. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.108863_bb0145","first-page":"1823","article-title":"Design, synthesis and biological evaluation of ciprofloxacin- peptide conjugates as anticancer agents","volume":"18","author":"Esfandiari Mazandaran","year":"2019","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2025.108863_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108324","article-title":"Tuning the lipophilicity of new ciprofloxacin derivatives in selected ESKAPE bacteria with emphasis on E. coli mutants","volume":"158","author":"Cassese","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100362","article-title":"6-gingerol enhances ciprofloxacin efficacy by inhibiting NorA efflux pump in Staphylococcus aureus","volume":"7","author":"Sau","year":"2025","journal-title":"The Microbe"},{"key":"10.1016\/j.bioorg.2025.108863_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molcatb.2007.03.007","article-title":"The study on efficient hydrolases immobilization for the kinetic resolution of the \u03b1-acetoxyamides","volume":"47","author":"Koszelewski","year":"2007","journal-title":"J. Mol. Catal. B Enzym."},{"key":"10.1016\/j.bioorg.2025.108863_bb0165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/14756360903373350","article-title":"Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects","volume":"25","author":"Sharma","year":"2010","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0170","first-page":"1","article-title":"Comparative dissolution profiles of representative quinolones in different media","volume":"21","author":"Akinleye","year":"2011","journal-title":"Nig. Q. J. Hosp. Med."},{"key":"10.1016\/j.bioorg.2025.108863_bb0175","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.bmc.2014.01.005","article-title":"Synthesis of novel, peptidic kinase inhibitors with cytostatic\/cytotoxic activity","volume":"22","author":"Szymanski","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/anie.201812668","article-title":"Identification and directed development of non-organic catalysts with apparent Pan-enzymatic mimicry into Nanozymes for efficient prodrug conversion","volume":"58","author":"Walther","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108863_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15257770902736442","article-title":"Synthesis of zidovudine derivatives with anti-HIV-1 and antibacterial activities","volume":"28","author":"Senthilkumar","year":"2009","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.bioorg.2025.108863_bb0190","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.aav7102","article-title":"Structural insight into substrate and inhibitor discrimination by human P-glycoprotein","volume":"363","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108863_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ph18060895","article-title":"Multidrug resistance: are we still afraid of the big bad wolf","volume":"18","author":"Alhazza","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bioorg.2025.108863_bb0200","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1021\/acschembio.2c00451","article-title":"Combinatorial anticancer drug screen identifies off-target effects of epigenetic chemical probes","volume":"17","author":"Barghout","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108863_bb0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2005.01.134","article-title":"Do drug substrates enter the common drug-binding pocket of P-glycoprotein through \u201cgates\u201d?","volume":"329","author":"Loo","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108863_bb0210","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature11448","article-title":"Crystal structure of the multidrug transporter P-glycoprotein from C. elegans","volume":"490","author":"Jin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108863_bb0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.csbj.2019.02.008","article-title":"An energetically favorable ligand entrance gate of a multidrug transporter revealed by partial nudged elastic band simulations","volume":"17","author":"Xing","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bioorg.2025.108863_bb0220","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cmdc.201200491","article-title":"Protein contacts and ligand binding in the inward-facing model of human P-glycoprotein","volume":"8","author":"Pajeva","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108863_bb0225","article-title":"Biological evaluation of medical devices\u2014part 5: tests for in vitro cytotoxicity","volume":"34","author":"ISO, 10993-5: 2009","year":"2009","journal-title":"Int. Organ. Stand. Geneva"},{"key":"10.1016\/j.bioorg.2025.108863_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.990241","article-title":"Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database","volume":"13","author":"Shu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108863_bb0235","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2478\/bvip-2013-0102","article-title":"Influence of fluoroquinolones on viability of Balb\/c 3T3 and HepG2 cells","volume":"57","author":"Radko","year":"2013","journal-title":"Bull. Vet. Inst. Pulawy"},{"key":"10.1016\/j.bioorg.2025.108863_bb0240","first-page":"901","article-title":"Triggering of erythrocyte membrane blebbing by ciprofloxacin","volume":"76","author":"Shabir","year":"2019","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.bioorg.2025.108863_bb0245","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1081\/JDI-120022557","article-title":"Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic Anemia","volume":"25","author":"Lim","year":"2003","journal-title":"Ren. Fail."},{"key":"10.1016\/j.bioorg.2025.108863_bb0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2018.09.067","article-title":"Fluoroquinolones and the risk of aortopathy: a systematic review and meta-analysis","volume":"274","author":"Noman","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioorg.2025.108863_bb0255","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161729","article-title":"Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm","volume":"8","author":"Xiang","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.bioorg.2025.108863_bb0260","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.18632\/oncotarget.2882","article-title":"Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells","volume":"6","author":"Kopecka","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108863_bb0265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00210-016-1266-y","article-title":"In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents","volume":"389","author":"Fusi","year":"2016","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108863_bb0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/jfb5020043","article-title":"HaCaT keratinocytes response on antimicrobial Atelocollagen substrates: extent of cytotoxicity, cell viability and proliferation","volume":"5","author":"L\u00f3pez-Garc\u00eda","year":"2014","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.bioorg.2025.108863_bb0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2025.108863_bb0280","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2025.108863_bb0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tiv.2017.07.015","article-title":"In vitro vascular toxicity of tariquidar, a potential tool for in vivo PET studies","volume":"44","author":"Durante","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bioorg.2025.108863_bb0290","doi-asserted-by":"crossref","DOI":"10.3791\/50166-v","article-title":"Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs","author":"Evans","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bioorg.2025.108863_bb0295","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/mp2001389","article-title":"Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human Cancer cells","volume":"8","author":"Riganti","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2025.108863_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112843","article-title":"One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells","volume":"208","author":"Contino","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108863_bb0305","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nano.2013.06.013","article-title":"Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition","volume":"10","author":"Kopecka","year":"2014","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.bioorg.2025.108863_bb0310","author":"MOE"},{"key":"10.1016\/j.bioorg.2025.108863_bb0315","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108863_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009016","article-title":"Human ABCB1 with an ABCB11-like degenerate nucleotide binding site maintains transport activity by avoiding nucleotide occlusion","volume":"16","author":"Goda","year":"2020","journal-title":"PLoS Genet."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:24:45Z","timestamp":1772803485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825007436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"alternative-id":["S0045206825007436"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108863","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New dimension of ciprofloxacin hybrids: Synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108863"}}